title: Lifestyle modification in the prevention and treatment of atrial fibrillation.
abstract: Atrial fibrillation (AF) is the most common arrhythmia worldwide and has a significant impact on morbidity and mortality. Additionally, the incidence and prevalence of AF is expected to increase in the United States and worldwide over the next few decades. While the pathophysiology concerning the development of AF is not completely understood, multiple modifiable, as well as non-modifiable risk factors, for AF development have been discovered. The goal of this paper is to provide an overview of the modifiable risk factors that contribute to the development and recurrence of AF, in addition to discussing potential lifestyle changes that may aid in the prevention and treatment of AF.
authors.affiliation: Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States.
authors.forename: Arthur R
authors.initials: AR
authors.lastname: Menezes
authors.affiliation: Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States. Electronic address: clavie@ochsner.org.
authors.forename: Carl J
authors.initials: CJ
authors.lastname: Lavie
authors.affiliation: Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States.
authors.forename: Alban
authors.initials: A
authors.lastname: De Schutter
authors.affiliation: Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States.
authors.forename: Richard V
authors.initials: RV
authors.lastname: Milani
authors.affiliation: Mid America Heart Institute, Kansas City, MI, United States.
authors.forename: James
authors.initials: J
authors.lastname: O'Keefe
authors.affiliation: Mid America Heart Institute, Kansas City, MI, United States.
authors.forename: James J
authors.initials: JJ
authors.lastname: DiNicolantonio
authors.affiliation: Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States.
authors.forename: Daniel P
authors.initials: DP
authors.lastname: Morin
authors.affiliation: Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States.
authors.forename: Freddy M
authors.initials: FM
authors.lastname: Abi-Samra
mesh_terms: D001281:Atrial Fibrillation / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control* / Q000628:therapy*; D015897:Comorbidity; D006801:Humans; D008019:Life Style; D011314:Preventive Health Services; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D016896:Treatment Outcome
keywords: Atrial fibrillation; Diabetes mellitus; Hypertension; Obesity; Obstructive sleep apnea